Authors: MaassenVanDenBrink, A Reekers, M Bax, WA Saxena, PR

Citation: A. Maassenvandenbrink et al., Human isolated coronary artery contraction to sumatriptan characterised bythe selective 5-HT1B/1D receptor antagonist GR55562, PHARM TOX, 86(6), 2000, pp. 287-290

Authors: MaassenVanDenBrink, A van den Broek, RWM de Vries, R Upton, N Parsons, AA Saxena, PR

Citation: A. Maassenvandenbrink et al., The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan, CEPHALALGIA, 20(6), 2000, pp. 538-545

Authors: van den Broek, RWM MaassenVanDenBrink, A de Vries, R Bogers, AJJC Stegmann, APA Avezaat, CJ Saxena, PR

Citation: Rwm. Van Den Broek et al., Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels, EUR J PHARM, 407(1-2), 2000, pp. 165-173

Authors: MaassenVanDenBrink, A Bax, WA Ramrattan, NN Ferrari, MD Saxena, PR

Citation: A. Maassenvandenbrink et al., Human isolated coronary artery contraction to sumatriptan: a post hoc analysis, CEPHALALGIA, 19(7), 1999, pp. 651-654

Authors: Roon, KI MaassenVanDenBrink, A Ferrari, MD Saxena, PR

Citation: Ki. Roon et al., Bovine isolated middle cerebral artery contractions to antimigraine drugs, N-S ARCH PH, 360(5), 1999, pp. 591-596

Authors: MaassenVanDenBrink, A de Vries, R Saxena, PR Schalekamp, MADH Danser, AHJ

Citation: A. Maassenvandenbrink et al., Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase, CARDIO RES, 44(2), 1999, pp. 407-415